Bajaj Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
311.40
8.95 (2.96%)
BSENSE

Mar 20

BSE+NSE Vol: 4.19 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
542.60
473.42
645.80
679.89
656.98
410.01
370.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
542.60
473.42
645.80
679.89
656.98
410.01
370.17
Raw Material Cost
371.42
394.89
512.64
556.40
517.54
356.34
326.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
57.06
43.85
42.32
41.11
34.55
28.18
24.62
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
27.90
29.68
17.56
12.62
8.30
6.45
8.02
Selling and Distribution Expenses
116.67
27.60
36.97
17.35
15.34
9.38
7.65
Other Expenses
-84.96
-73.53
-59.88
-53.73
-42.84
-34.63
-32.64
Total Expenditure (Excl Depreciation)
488.09
422.48
549.62
573.75
532.87
365.72
333.82
Operating Profit (PBDIT) excl Other Income
54.51
50.93
96.18
106.14
124.11
44.29
36.35
Other Income
19.40
0.07
-1.24
-3.66
2.31
-3.19
-4.52
Operating Profit (PBDIT)
101.83
34.30
112.13
119.93
143.24
52.88
43.22
Interest
27.90
29.68
17.56
12.62
8.30
6.45
8.02
Exceptional Items
0.00
6.32
0.82
0.02
0.00
1.75
0.38
Gross Profit (PBDT)
171.18
78.53
133.15
123.49
139.45
53.67
44.00
Depreciation
27.92
27.62
17.21
17.64
16.12
12.12
11.41
Profit Before Tax
46.01
-16.68
78.18
89.68
118.82
36.06
24.17
Tax
3.08
-2.35
14.65
18.30
35.71
10.82
7.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
42.93
-14.33
63.53
71.39
83.11
25.24
16.31
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
42.93
-14.33
63.53
71.39
83.11
25.24
16.31
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
42.93
-14.33
63.53
71.39
83.11
25.24
16.31
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
5.0
5.0
5.0
10.0
10.0
10.0
10.0
Reserves
466.16
278.36
367.69
328.49
258.41
177.93
129.11
Earnings per share (EPS)
13.12
-30.36
15.59
25.87
30.11
9.14
5.91
Diluted Earnings per share
13.12
-30.36
15.59
25.87
30.11
9.14
5.91
Operating Profit Margin (Excl OI)
10.05%
1.4%
14.89%
15.58%
19.0%
10.72%
9.81%
Gross Profit Margin
13.62%
2.31%
14.77%
15.79%
20.54%
11.75%
9.61%
PAT Margin
7.91%
-3.03%
9.84%
10.5%
12.65%
6.16%
4.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 399.58% vs -122.56% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 140.81% vs -69.81% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -6.00% vs 69.02% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Bajaj Healthcare With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
542.60
469.48
73.12
15.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
542.60
469.48
73.12
15.57%
Raw Material Cost
371.42
129.95
241.47
185.82%
Purchase of Finished goods
0
59.66
-59.66
-100.00%
(Increase) / Decrease In Stocks
0
-31.16
31.16
100.00%
Employee Cost
57.06
65.10
-8.04
-12.35%
Power Cost
0
0.00
0.00
Manufacturing Expenses
27.90
-0.01
27.91
279,100.00%
Selling and Distribution Expenses
116.67
0.00
116.67
Other Expenses
-84.96
136.14
-221.10
-162.41%
Total Expenditure (Excl Depreciation)
488.09
359.68
128.41
35.70%
Operating Profit (PBDIT) excl Other Income
54.51
109.80
-55.29
-50.36%
Other Income
19.40
11.82
7.58
64.13%
Operating Profit (PBDIT)
101.83
121.62
-19.79
-16.27%
Interest
27.90
14.19
13.71
96.62%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
171.18
107.43
63.75
59.34%
Depreciation
27.92
24.22
3.70
15.28%
Profit Before Tax
46.01
83.21
-37.20
-44.71%
Tax
3.08
6.81
-3.73
-54.77%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
42.93
76.40
-33.47
-43.81%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0.00
0.00
Other Adjustments
0
0.00
0.00
Net Profit
42.93
76.40
-33.47
-43.81%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
0.00
0.46
-0.46
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
42.93
76.86
-33.93
-44.15%
Equity Capital
0
14.58
-14.58
-100.00%
Face Value
5.00
5.00
0.00
Reserves
466.16
348.09
118.07
33.92%
Earnings per share (EPS)
13.12
26.36
-13.24
-50.23%
Diluted Earnings per share
13.12
26.35
-13.23
-50.21%
Operating Profit Margin (Excl OI)
10.05%
23.39%
0.00
-13.34%
Gross Profit Margin
13.62%
22.88%
0.00
-9.26%
PAT Margin
7.91%
16.27%
0.00
-8.36%
Public Share Holdings (%)
0%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 542.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 42.93 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 399.58% vs -122.56% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.43 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 140.81% vs -69.81% in Mar 2024

Annual - Interest
Interest 27.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -6.00% vs 69.02% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.05%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024